Floatz logo

SACUBITRIL VALSARTAN

Impaired Glucose Tolerance

Ohio State UniversitySmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Impaired Glucose Tolerance cohort.

Asset / SponsorPhaseRating
Metformin
Yu Chen
Phase 4A
Liraglutide
Woman's
Phase 4BBB
Exenatide
RenJi Hospital
Phase 4BBB
Pioglitazone
VA Office of Research and Development
Phase 4BB
Rosiglitazone
University of Chicago
Phase 2/3BB

View all 18 →

Same molecule, other indications

SACUBITRIL VALSARTAN is also rated in:

Blood PressureDormant
BB
Indicative ·
65 / 100
View asset →
breast neoplasmDormant
BB
Indicative ·
65 / 100
View asset →
breast disorderDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →